Mejías-Trueba Marta, Rodríguez-Pérez Aitana, García-Cabrera Emilio, Jiménez-Juan Carlos, Sánchez-Fidalgo Susana
Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Departamento de Enfermedades Infecciosas, Microbiología y Parasitología, Grupo de Investigación en Enfermedades Infecciosas, Instituto de Biomedicina de Sevilla, Universidad de Sevilla/Consejo Superior de Investigaciones Científicas/Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Healthcare (Basel). 2023 Jun 29;11(13):1879. doi: 10.3390/healthcare11131879.
There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who care for multipathological patients.
The "" was adapted to an online format and sent to physicians in geriatrics. Question 1 is a reference to establish agreement or disagreement with this practice. The influence of different aspects of deprescription was analysed via the demographic characteristics of the clinicians and perceptions of the various barriers (questions 2-9) by means of bivariate analysis. Based on the latter, a multivariate model was carried out to demonstrate the relationship between barriers and the degree of deprescription agreement among respondents.
Of the 72 respondents, 72.2% were in favour of deprescribing. Regarding the analyses, the demographic characteristics did not influence rankings. The deprescription of preventive drugs and consensus with patients were associated with a positive attitude towards deprescribing, while withdrawing drugs prescribed by other professionals, time constraints and patient reluctance emerged as possible barriers. The only factor independently associated with deprescribing was lack of time.
Time was found to be the main barrier to deprescription. Training, the creation of multidisciplinary teams and integrated health systems are key facilitators.
减药存在障碍,阻碍其在临床实践中的实施。本研究的目的是分析照顾多病患者的医生所感知到的减药过程的主要障碍和局限性。
将“”改编为在线形式并发送给老年医学医生。问题1是用于确定对这种做法的同意或不同意。通过双变量分析,根据临床医生的人口统计学特征和对各种障碍的看法(问题2 - 9)分析减药不同方面的影响。基于后者,进行多变量模型以证明障碍与受访者中减药同意程度之间的关系。
在72名受访者中,72.2%赞成减药。关于分析,人口统计学特征不影响排名。预防性药物的减药以及与患者的共识与对减药的积极态度相关,而停用其他专业人员开具的药物、时间限制和患者的不情愿成为可能的障碍。与减药独立相关的唯一因素是时间不足。
发现时间是减药的主要障碍。培训、创建多学科团队和综合卫生系统是关键的促进因素。